Sandip Kapadia
2019 - Intercept Pharmaceuticals
Compensation breakdown
| Non-Equity Incentive Plan | $252,935 |
|---|---|
| Option Awards | $586,573 |
| Salary | $464,100 |
| Stock Awards | $1,001,664 |
| Other | $21,368 |
| Total | $2,326,640 |
Kapadia received $1M in stock awards, accounting for 43% of the total pay in 2019.
Kapadia also received $252.9K in non-equity incentive plan, $586.6K in option awards, $464.1K in salary and $21.4K in other compensation.
Rankings
In 2019, Sandip Kapadia's compensation ranked 5,188th out of 13,971 executives tracked by ExecPay. In other words, Kapadia earned more than 62.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,188 out of 13,971 | 63rd |
Division Manufacturing | 1,929 out of 5,701 | 66th |
Major group Chemicals And Allied Products | 678 out of 2,200 | 69th |
Industry group Drugs | 569 out of 1,886 | 70th |
Industry Pharmaceutical Preparations | 425 out of 1,398 | 70th |
Pay ratio
| Sandip Kapadia's Pay | $2,326,640 |
|---|---|
| Median Employee's Pay | $239,066 |
| Pay Ratio | 10to 1 |
In 2019, the annual total compensation of Sandip Kapadia was $2,326,640.
The annual total compensation of the median employee at Intercept Pharmaceuticals was $239,066.
The ratio of Sandip Kapadia's pay to the pay of median employee was therefore 10 to one.
Kapadia's colleagues
We found four more compensation records of executives who worked with Sandip Kapadia at Intercept Pharmaceuticals in 2019.
News
May 2, 2022
April 8, 2022
April 27, 2021
April 29, 2020
April 30, 2019